Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Carbon nanotubes (CNT)-loaded ginsenosides Rb3 suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer
Xiao Luo, Hui Wang, Degang Ji
Aging (2021) Vol. 13, Iss. 13, pp. 17177-17189
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities
Brijendra Kumar Kashyap, Virendra Singh, Manoj Kumar Solanki, et al.
ACS Omega (2023) Vol. 8, Iss. 16, pp. 14290-14320
Open Access | Times Cited: 163
Insights on functionalized carbon nanotubes for cancer theranostics
Lu Tang, Qiaqia Xiao, Yijun Mei, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 119
Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets
Zhangfeng Zhong, Chi Teng Vong, Feiyu Chen, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1246-1279
Open Access | Times Cited: 76
Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti-cancer evaluation of peritumoral hydrogel injection combined with PD-L1 antibody
Hao Wu, Guoli Wei, Lixia Luo, et al.
Biomaterials Research (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 47
Properties and applications of boron nitride nanotubes
Emine Ayşe Turhan, Ahmet Engin Pazarçeviren, Zafer Evis, et al.
Nanotechnology (2022) Vol. 33, Iss. 24, pp. 242001-242001
Closed Access | Times Cited: 44
Nano-drug Delivery System: a Promising Approach Against Breast Cancer
Jonaid Ahmad Malik, Jeba Ajgar Ansari, Sakeel Ahmed, et al.
Therapeutic Delivery (2023) Vol. 14, Iss. 5, pp. 357-381
Open Access | Times Cited: 23
Enhancing cancer immunotherapy: Exploring strategies to target the PD-1/PD-L1 axis and analyzing the associated patent, regulatory, and clinical trial landscape
S. S. Kirthiga Devi, S. D. Singh, Ramesh Joga, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 200, pp. 114323-114323
Closed Access | Times Cited: 10
Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 542-542
Open Access | Times Cited: 32
Special Issue: Nanotherapeutics in Women's Health Emerging Nanotechnologies for Triple‐Negative Breast Cancer Treatment
Sofia Torres Quintas, Ana Manuela Canha Borges, Maria José Oliveira, et al.
Small (2023)
Open Access | Times Cited: 22
Theranostics for Triple-Negative Breast Cancer
Hye Ryeon Choi, Kwangsoon Kim
Diagnostics (2023) Vol. 13, Iss. 2, pp. 272-272
Open Access | Times Cited: 20
Ginsenosides are Promising Medicine for Tumor and Inflammation: A Review
Jiawei Li, Fangfang Li, Dan Jin
The American Journal of Chinese Medicine (2023) Vol. 51, Iss. 04, pp. 883-908
Closed Access | Times Cited: 19
Carbon nanotubes: A review on synthesis and drug delivery for cancer treatment
Mohammed Faiad Naief, Samar Naser Mohammed, Ahmed Mishaal Mohammed
Inorganic Chemistry Communications (2023) Vol. 159, pp. 111694-111694
Closed Access | Times Cited: 18
Strategies for Remodeling the Tumor Microenvironment Using Active Ingredients of Ginseng—A Promising Approach for Cancer Therapy
Mo Li, Xin Wang, Ying Wang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 28
A review of nanomaterials from synthetic and natural molecules for prospective breast cancer nanotherapy
Pankaj Kumar, Bharti Mangla, Shamama Javed, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Biomacromolecule-based nanocarrier strategies to deliver plant-derived bioactive components for cancer treatment: A recent review
Bapi Gorain, Varnita Karmakar, Biswatrish Sarkar, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126623-126623
Closed Access | Times Cited: 11
Recent advances in delivery systems of ginsenosides for oral diseases
Yuqing Gu, Ze Li, Shu Zhou, et al.
Phytomedicine (2025), pp. 156422-156422
Closed Access
Biogenic nanoparticles: Understanding their potential role in cancer theranostics
Durdana Yasin, Neha Sami, Bushra Afzal, et al.
Next Nanotechnology (2025) Vol. 8, pp. 100149-100149
Open Access
Age-related and postmenopausal breast cancer progression and treatment management: The significance of pro-inflammatory cytokines and CXC chemokines
Amin Ullah, Rajeev K. Singla, Dan Cao, et al.
Genes & Diseases (2025), pp. 101606-101606
Open Access
Research progress of nano drug delivery systems in the anti-tumor treatment of traditional Chinese medicine monomers
Bocui Song, Shuang Li, Shuang Zhang, et al.
PeerJ (2025) Vol. 13, pp. e19332-e19332
Open Access
Integration of active ingredients from traditional Chinese medicine with nano-delivery systems for tumor immunotherapy
Hao Zheng, Yiquan Chen, Wei Luo, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Preparation and pharmacological effects of minor ginsenoside nanoparticles: a review
Yue Ke, Lei Huang, Yu Song, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Unveiling the experimental proof of the anticancer potential of ginsenoside Rg3 (Review)
Yongmin Liu, Guanchu Li, Jinyue Ning, et al.
Oncology Letters (2024) Vol. 27, Iss. 4
Open Access | Times Cited: 3
Research progress of ginseng in the treatment of gastrointestinal cancers
Baoyi Ni, Xiaotong Song, Bolun Shi, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer
Ruiyuan Jiang, Ziru Fang, Huanping Zhang, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 7
The role of IL-22 in cancer
Zachary E. Hunzeker, Lei Zhao, Austin M. Kim, et al.
Medical Oncology (2024) Vol. 41, Iss. 10
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top